| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,138 | 12,661 | 12,737 | 11,995 | | Cost of Revenue | 2,862 | 2,474 | 2,704 | 2,259 | | | Gross Profit | 10,276 | 10,187 | 10,033 | 9,736 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,825 | 1,878 | 1,446 | 1,533 | | Non Recurring |
-
|
-
|
-
| 2,100 | | Others | 543 | 4,406 | 3,327 | 4,208 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (15,623) | 3,903 | 5,260 | 1,895 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 18,243 | 32,252 | (23,074) | 20,283 | | Earnings Before Interest And Taxes | 11,729 | (66,598) | (17,864) | (49,590) | | Interest Expense | 4,297 | 4,433 | 4,398 | 5,168 | | Income Before Tax | 7,432 | (71,031) | (22,262) | (54,758) | | Income Tax Expense | 14 | 147 | 50 | 330 | | Minority Interest |
-
|
-
|
-
| (219) | | | | Net Income From Continuing Ops | 15,472 | (71,031) | (22,262) | (54,494) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 1,834 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 14,821 | (71,031) | (22,262) | (52,660) | | Preferred Stock And Other Adjustments | 336 | (165) | (171) |
-
| | | Net Income Applicable To Common Shares | $15,157 | ($71,196) | ($22,433) | ($52,660) |
|
0.51% Nasdaq 
Income Statement
